Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review

Sulodexide is a heterogeneous group of sulfated glycosaminoglycans (GAGs) that is mainly composed of low-molecular-weight heparin. Clinical studies have demonstrated that sulodexide is capable of reducing urinary albumin excretion rates in patients with type 1 and type 2 diabetes, suggesting that su...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Xing, Jing, Mu, Xaojing, Wang, Hui, Zhang, Lei, Zhao, Yu, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671764/
https://www.ncbi.nlm.nih.gov/pubmed/26664049
http://dx.doi.org/10.2147/DDDT.S87973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671764/
https://www.ncbi.nlm.nih.gov/pubmed/26664049
http://dx.doi.org/10.2147/DDDT.S87973

Ejemplares similares